Health care shares are higher in late-session trading while Merck & Co. (MRK) gets a key approval for one of its HIV medications.
The U.S. Food and Drug Administration approved an expanded label for MRK's HIV treatment that is used in conjunction with other antiretroviral drugs in children.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.